Ramucirumab

Category: Cancer



Ramucirumab Overview

Ramucirumab[1] (LY3009806, IMC-1121B, trade name Cyramza[2][3]) is a fully human monoclonal antibody (IgG1) developed for the treatment of solid tumors. This drug was developed by ImClone Systems Inc. It was isolated from a native phage display library from Dyax. Contents 1 Approved uses 2 Contraindications 3 Side effects 4 Interactions 5 Pharmacology 5.1 Mechanism of action 6 Clinical trials 7 References Approved uses On 21 April ...

Read more Ramucirumab Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Ramucirumab

Recent Ramucirumab Forums: RSS Feed

bleeding - out

Bleeding-out is a slight possibility if you take ramucirumab. Do we know if there was anything in the profiles of those who bled-out that we can discern whether we will likely bleed-out? Was bleeding up front, or anytime during the time they took the drug? Was bleeding-out an "all at once" thing, or was it spread out? Can you likely be saved by the emergency room procedures? ## Hello, Ron! How are you? No, there is nothing that's been found to pinpoint anyone being more susceptible to bleeding out than anyone else. Bleeding out is actually considered to be sudden, heavy bleeding that can result in death within a very short period of time. If the person is bleeding more gradually over a 'spread out' period of time, there is a chance of combatting it by having them sto...

Updated

Possible Dosages for this and Related Drugs:

Ramucirumab
  • Injection: 100mg/10ml, 500mg/50ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Ramucirumab or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 23 January 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA